Melinta Medical Affairs

Congress Presentations

Presentations Focused on Melinta and Partner Anti-Infectives

Requesting Presentations

Check the boxes next to presentations you're interested in, then click the "Request Selected Materials" button that will appear above.

0 presentations selected
Click the button to request the materials.
 

IDWEEK

Tuesday, October 21st

Novel Agents
P-1196 - Geographic distribution, MIC testing, and susceptibility rates of Candida auris isolates collected in the United States since 2014
Marisa L Winkler, John H. Kimbrough, Kelley Fedler, Samuel Edeker, Abby Klauer, Paul Rhomberg, Mariana Castanheira
P-1200 - Real-World Utilization of Rezafungin in the Outpatient Setting
Nicholas W. Van Hise, Mark Redell, Jalal A. Aram, Vishnu Chundi, Ingrid Roig, Bala Somayaji, Samir Allos, Jaime Belmares, Michael Anderson, Robert Fliegelman, Russell M. Petrak
P-1210 - Real-World Efficacy and Safety of Meropenem-Vaborbactam in Patients with Moderate to Severe Renal Impairment
Sean R. Van Helden, Kaylee E. Caniff, Mohammed Al Musawa, Sara Alosaimy, Abdalhamid M Lagnf, Chloe Judd, Marco R Scipione, Jing J Zhao, Taryn A. Eubank, Kevin W. Garey, Wesley D. Kufel, Tamara Krekel, Karen K. Tan, Elisabeth L. Chandler, Jacqueline A. Aramburo, Dev Chatterji, Samantha D. Walker, Christine N. Yost, Jacqueline M. Muscat, Justin Andrade, John Cerenzio, Karan Raja, Taylor Morrisette, Sarah C J Jorgensen, Ryan Mynatt, Travis J Carlson, David Allen, Kailynn DeRonde, Ana D Vega, Lilian M Abbo, Veena Venugopalan, Vasilios Athans, Stephen Saw, Kimberly C Claeys, Mathew Miller, Kyle C Molina, Lee Amaya, Jessica Ortwine, Susan L Davis, Michael P. Veve, Michael J. Rybak
Treatment of Antimicrobial-Resistant Infections
P-1340 - Activity of Delafloxacin and Comparator Agents Against Bacterial Isolates From Patients with Diabetic Foot Infection in the United States and Europe (2017–2023)
Michael D Huband, Marisa L Winkler, Kelley A Fedler, Mariana Castanheira

Wednesday, October 22nd

Medical Mycology
P-1958 - Efficacy and Safety of Rezafungin, A Long-Acting Echinocandin
Richard L. Hengel; Brian S. Metzger; Erika M. Young; Kent J. Stock; Joseph F. John, Jr. ; Kimberly A. Couch; Christina Weeks; Lucinda J. Van Anglen (Healix)

Email

medinfo@melinta.com
or click here to access
our online form.

Report an Adverse Event or Quality Complaint

Call 1-844-MED-MLNT
(+1 844-633-6568).
You may also report suspected
adverse events to the FDA
at 1-800-FDA-1088 or
https://www.fda.gov/medwatch

Scan

Access Melinta Medical
Information Library

Call

1-844-med-mlnt
(+1 844-633-6568)
to speak with a medical
information representative
0 presentations selected

Email

medinfo@melinta.com
“AE”

Report an Adverse Event
or Quality Complaint

Call 1-844-MED-MLNT
(+1 844-633-6568).
You may also report suspected
adverse events to the FDA
at 1-800-FDA-1088 or
https://www.fda.gov/medwatch
“QR”

Call

1-844-MED-MLNT
(+1 844-633-6568)
to speak with a Medical
Information Representative